Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100
Closed -$6.83K 114
2025
Q1
$6.83K Hold
100
﹤0.01% 105
2024
Q4
$7.78K Hold
100
﹤0.01% 99
2024
Q3
$6.7K Hold
100
﹤0.01% 98
2024
Q2
$11.3K Hold
100
0.01% 104
2024
Q1
$14 Hold
100
﹤0.01% 94
2023
Q4
$12 Buy
+100
New +$10.2K ﹤0.01% 93

Other funds holding DXCM

MN Wealth Advisors's DXCM Position: Q2 2026 in Review

MN Wealth Advisors reduced its DexCom (DXCM) stake by 46% in Q2 2026, selling an estimated $187K and leaving 3,337 shares worth $225K. The position accounts for 0.1% of the portfolio, ranked #123.

MN Wealth Advisors first reported a position in DXCM in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.58M in Q4 2024. 224 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • MN Wealth Advisors held 3,337 shares of DexCom worth $225K as of Q2 2026.
  • MN Wealth Advisors sold 2,804 DexCom shares in Q2 2026, an estimated $187K.
  • DexCom made up 0.1% of MN Wealth Advisors's portfolio in Q2 2026, its #123 holding.
  • MN Wealth Advisors first reported a position in DexCom in Q4 2023 and has held it in 11 quarters since.
  • MN Wealth Advisors's DexCom position peaked at $1.58M in Q4 2024.
  • 224 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on MN Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.